CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Korean red ginseng +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00976274
NCT00976274N/ACompleted
CompareCT.gov

Effects of Korean Red Ginseng on Cardiovascular Risks in Subjects With Metabolic Syndrome

The Korean Society of Ginseng·interventional·Posted Sep 14, 2009·Updated Feb 27, 2012

In Brief

A clinical study evaluating Korean red ginseng and starch for Metabolic Syndrome. Completed, enrolled 60 participants across 1 site.

Detailed Summary

Five factor consisting of Metabolic syndrome is closely linked by insulin resistance. Until now, several studies have been performed about effects of Korea red ginseng on hypertension, diabetes, and hyperlipidemia, but not metabolic syndrome. The investigators hypothesize that Korean red ginseng could improve each constituents of metabolic syndrome, arterial stiffness, and inflammatory markers. The aim of this study is to determine effects of Korean red ginseng on cardiovascular risks in subjects with metabolic syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetabolic Syndrome
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 14, 2009
Enrollment StartAug 1, 2009
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 16.8 years ago

Interventions

Korean red ginsengdietary

5 capsules (300 mg/capsule) three times everyday for 12 weeks

starchdietary

5 capsules three times everyday for 12 weeks